Hyperargininemia: Clinical Trials

2 trials for Hyperargininemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Hyperargininemia: new trials by email Literature Review of Hyperargininemia trials Research Report on Hyperargininemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency
Pegzilarginase - Arginase 1 Deficiency
Phase 3CompletedImmedica Pharma AB32024-08-302026-05-22
Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency
Pegzilarginase, Placebo - Arginase I Deficiency, Hyperargininemia
Phase 3CompletedImmedica Pharma AB322019-05-012026-08-21

Broader conditions

Amino Acid Metabolism, Inborn Errors (2)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Nervous System Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Urea Cycle Disorders, Inborn (2)

Sponsors

Immedica Pharma AB (2)

Countries

Austria (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Portugal (1)  ·  United States (1)

Top investigators

Mattias Rudebeck, PhD MSc BMedSc (2)

Results publications

PMID 38292042